Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Total Current Liabilities (2020 - 2026)

Core Scientific has reported Total Current Liabilities over the past 7 years, most recently at $2.7 billion for Q1 2026.

  • Quarterly results put Total Current Liabilities at $2.7 billion for Q1 2026, up 1261.46% from a year ago — trailing twelve months through Mar 2026 was $2.7 billion (up 1261.46% YoY), and the annual figure for FY2025 was $781.4 million, up 480.7%.
  • Total Current Liabilities reached $2.7 billion in Q1 2026 per CORZ's latest filing, up from $781.4 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $2.7 billion in Q1 2026 and bottomed at $74.8 million in Q2 2024.
  • Median Total Current Liabilities over the past 5 years was $312.7 million (2023), compared with a mean of $523.2 million.
  • The largest annual shift saw Total Current Liabilities skyrocketed 50006.93% in 2022 before it plummeted 75.74% in 2023.
  • Over 5 years, Total Current Liabilities stood at $186.8 million in 2022, then surged by 161.48% to $488.4 million in 2023, then tumbled by 72.45% to $134.6 million in 2024, then soared by 480.7% to $781.4 million in 2025, then soared by 240.64% to $2.7 billion in 2026.
  • Business Quant data shows Total Current Liabilities for CORZ at $2.7 billion in Q1 2026, $781.4 million in Q4 2025, and $669.9 million in Q3 2025.